Cohance Lifesciences Limited
NSE: COHANCE | Information Technology
Market Fundamentals
Stock Intelligence & News
Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Credit Rating- Others |SUBJECT: Credit Rating- Others
Read Full Analysis →Cohance Lifesciences Ltd (543064)
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Cohance Lifesciences Stock Jumps Over 2% Despite Poor Q1 Earnings; Here's Why
Cohance Lifesciences shares traded higher despite reporting one of its weakest quarterly performances.
Read Full Analysis →Cohance Lifesciences Q1 Review: Brokerages Split After Earnings Slump — Check Potential Upside, Target Price
Macquarie retained its Outperform rating on Cohance Lifesciences despite a weaker-than-expected June quarter, while Jefferies maintained Underperform as sales declines across businesses pushed EBITDA close to break-even.
Read Full Analysis →Stocks to watch: Oil India, Infosys, NBCC, Zee, Cohance Life, Gland Pharma, Neuland Lab, Monarch Surveyors, RMC Switchgears
Key developments include Infosys partnering with Metsä Group for IT modernisation, Cohance Lifesciences under USFDA scrutiny, and Gland Pharma teaming up with Neuland Labs to boost sterile API production.
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
Read Full Analysis →Cohance Lifesciences Limited
Cohance Lifesciences Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2026 . |SUBJECT: Board Meeting Intimation
Read Full Analysis →Cohance Lifesciences Limited
Financial Results |Meeting Date: 05-Aug-2026
Read Full Analysis →10 Nifty 500 stocks plunge over 50% from 52-week highs. Do you own any?
Nifty 500 stocks experienced sharp declines, far exceeding index movements. Several companies saw their values drop by over fifty percent from recent highs. Reliance Power and Cohance Lifesciences are among the biggest losers in this market correction.
Read Full Analysis →Get instant alerts when COHANCE breaks news
Join investors who track Cohance Lifesciences Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for COHANCE?
COHANCE is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Cohance Lifesciences Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding COHANCE to your custom watchlist.